Literature DB >> 34633608

Circ_0075804 promotes the malignant behaviors of retinoblastoma cells by binding to miR-138-5p to induce PEG10 expression.

Yanling Zhang1, Xiaoyan Dou2, Qinghui Kong2, Yuying Li3, Xing Zhou4.   

Abstract

BACKGROUND: It has been gradually recognized that circular RNAs (circRNAs) are important modulators in multiple malignancies. Here, we analyzed the function of circ_0075804 and explored its associated mechanism in regulating retinoblastoma (RB) progression.
METHODS: Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot assay were utilized to measure RNA and protein expression, respectively. Cell proliferation was analyzed by Cell counting kit-8 (CCK8) assay and 5-Ethynyl-2'-deoxyuridine (EdU) assay. Cell apoptosis was assessed by flow cytometry. Cell migration and invasion abilities were analyzed by wound healing assay and transwell invasion assay. Dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were applied to verify intermolecular target relations. Xenograft tumor model was used to analyze the role of circ_0075804 in tumor growth in vivo.
RESULTS: Circ_0075804 expression was markedly up-regulated in RB tissues and cell lines. Circ_0075804 knockdown restrained the proliferation, migration and invasion whereas promoted the apoptosis of RB cells. Circ_0075804 acted as a molecular sponge for microRNA-138-5p (miR-138-5p), and circ_0075804 silencing-induced effects were partly reversed by miR-138-5p knockdown in RB cells. MiR-138-5p interacted with the 3' untranslated region (3'UTR) of paternally expressed 10 (PEG10). Circ_0075804 positively regulated PEG10 level by sponging miR-138-5p in RB cells. PEG10 overexpression largely overturned miR-138-5p overexpression-mediated effects in RB cells. Circ_0075804 knockdown blocked xenograft tumor growth in vivo.
CONCLUSION: Circ_0075804 promoted RB progression via miR-138-5p-dependent regulation of PEG10, which provided new insight in RB therapy.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Circ_0075804; PEG10; Retinoblastoma; miR-138-5p

Mesh:

Substances:

Year:  2021        PMID: 34633608     DOI: 10.1007/s10792-021-02067-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  29 in total

Review 1.  Basic understanding of current classification and management of retinoblastoma.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Curr Opin Ophthalmol       Date:  2006-06       Impact factor: 3.761

Review 2.  Circular RNA: A new star of noncoding RNAs.

Authors:  Shibin Qu; Xisheng Yang; Xiaolei Li; Jianlin Wang; Yuan Gao; Runze Shang; Wei Sun; Kefeng Dou; Haimin Li
Journal:  Cancer Lett       Date:  2015-06-05       Impact factor: 8.679

Review 3.  Regulation of circRNA biogenesis.

Authors:  Ling-Ling Chen; Li Yang
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 4.  Circular RNAs in cancer: novel insights into origins, properties, functions and implications.

Authors:  Jingqiu Li; Jie Yang; Ping Zhou; Yanping Le; Chengwei Zhou; Shaomin Wang; Dazhi Xu; Hui-Kuan Lin; Zhaohui Gong
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

Review 5.  The management of retinoblastoma.

Authors:  Ido D Fabian; Zerrin Onadim; Esin Karaa; Catriona Duncan; Tanzina Chowdhury; Irene Scheimberg; Shin-Ichi Ohnuma; M Ashwin Reddy; Mandeep S Sagoo
Journal:  Oncogene       Date:  2018-01-11       Impact factor: 9.867

6.  MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK.

Authors:  Wei Zhang; Kai Liao; Dongning Liu
Journal:  Cancer Manag Res       Date:  2020-09-08       Impact factor: 3.989

7.  Circular RNA (circ-0075804) promotes the proliferation of retinoblastoma via combining heterogeneous nuclear ribonucleoprotein K (HNRNPK) to improve the stability of E2F transcription factor 3 E2F3.

Authors:  Wenbo Zhao; Shuai Wang; Tingyu Qin; Wenzhan Wang
Journal:  J Cell Biochem       Date:  2020-02-17       Impact factor: 4.429

8.  Natural RNA circles function as efficient microRNA sponges.

Authors:  Thomas B Hansen; Trine I Jensen; Bettina H Clausen; Jesper B Bramsen; Bente Finsen; Christian K Damgaard; Jørgen Kjems
Journal:  Nature       Date:  2013-02-27       Impact factor: 49.962

9.  Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis.

Authors:  Qiuling Liu; Yafeng Wang; Han Wang; Yingying Liu; Tao Liu; Patricia Elena Kunda
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-21       Impact factor: 4.553

Review 10.  CircRNA: functions and properties of a novel potential biomarker for cancer.

Authors:  Shujuan Meng; Hecheng Zhou; Ziyang Feng; Zihao Xu; Ying Tang; Peiyao Li; Minghua Wu
Journal:  Mol Cancer       Date:  2017-05-23       Impact factor: 27.401

View more
  2 in total

Review 1.  CircRNA-Associated CeRNAs Regulatory Axes in Retinoblastoma: A Systematic Scoping Review.

Authors:  Mohammad Reza Asadi; Marziyeh Sadat Moslehian; Hani Sabaie; Mirmohsen Sharifi-Bonab; Parvin Hakimi; Bashdar Mahmud Hussen; Mohammad Taheri; Azadeh Rakhshan; Maryam Rezazadeh
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

Review 2.  Applications of Non-Coding RNAs in Patients With Retinoblastoma.

Authors:  Daniel Fernandez-Diaz; Cristina Rodriguez-Vidal; Paula Silva-Rodríguez; Laura Paniagua; María José Blanco-Teijeiro; María Pardo; Antonio Piñeiro; Manuel Bande
Journal:  Front Genet       Date:  2022-03-31       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.